These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 30201547)

  • 21. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    Yue C; Li G; Wen Y; Li X; Gao R
    J Rheumatol; 2018 May; 45(5):655-662. PubMed ID: 29449503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.
    Wetmore JB; Tang F; Sharma A; Jones PG; Spertus JA
    Am Heart J; 2015 Oct; 170(4):735-43. PubMed ID: 26386797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
    Navaneethan SD; Nigwekar SU; Sehgal AR; Strippoli GF
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):542-51. PubMed ID: 19261819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    Bhandari S; Mehta S; Khwaja A; Cleland JGF; Ives N; Brettell E; Chadburn M; Cockwell P;
    N Engl J Med; 2022 Dec; 387(22):2021-2032. PubMed ID: 36326117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.
    Gentile G; Remuzzi G; Ruggenenti P
    Nephron; 2015; 129(1):39-41. PubMed ID: 25531311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes of Renin-Angiotensin-Aldosterone Blockade in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Vendeville N; Lepage MA; Festa MC; Mavrakanas TA
    Can J Cardiol; 2024 Sep; 40(9):1718-1728. PubMed ID: 38458564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
    Voskamp PWM; Dekker FW; van Diepen M; Hoogeveen EK;
    J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA; Onuigbo NT
    Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
    Ruggiero B; Trillini M; Tartaglione L; Rotondi S; Perticucci E; Tripepi R; Aparicio C; Lecchi V; Perna A; Peraro F; Villa D; Ferrari S; Cannata A; Mazzaferro S; Mallamaci F; Zoccali C; Bellasi A; Cozzolino M; Remuzzi G; Ruggenenti P; Kohan DE;
    Am J Kidney Dis; 2019 Sep; 74(3):338-350. PubMed ID: 31027883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
    Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients.
    Onuigbo MA; Onuigbo NT
    Int Urol Nephrol; 2008; 40(1):233-9. PubMed ID: 18196471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Use of Renin-Angiotensin System Inhibitors in Patients With Chronic Kidney Disease.
    Leon SJ; Tangri N
    Can J Cardiol; 2019 Sep; 35(9):1220-1227. PubMed ID: 31472818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment.
    Higuchi S; Kohsaka S; Shiraishi Y; Katsuki T; Nagatomo Y; Mizuno A; Sujino Y; Kohno T; Goda A; Yoshikawa T;
    Eur J Intern Med; 2019 Apr; 62():58-66. PubMed ID: 30737061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.